Abbott: Heart Diseases trials

The registry lists 29 Heart Diseases studies with Abbott as lead sponsor. 5 are open to participants now and 14 have results posted.

Phase 2 1Phase 3 6Phase 4 2No phase 21(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Left Bundle Branch Area Pacing (LBBAP) PMCF StudyRecruitingNCT07217392Not applicable
• Health App Data Collection StudyEnrolling by invitationNCT06595615
• Abbott Structural Heart Device RegistryRecruitingNCT06590467
• Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart FailureRecruitingNCT06526195Not applicable
• ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve ImplantationEnrolling by invitationNCT05932615Not applicable
• Feasibility Study of the Tendyne Mitral Valve System in Mitral Annular CalcificationCompletedNCT03539458Not applicableResults posted
• Absorb GT1 Japan PMSCompletedNCT03409731Not applicableResults posted
• XIENCE Xpedition Everolimus-Eluting Coronary Stent Japan Post Marketing Surveillance (XIENCE Xpedition SV Japan PMS)CompletedNCT02513732Results posted
• XIENCE PRIME SV Everolimus Eluting Coronary Stent Japan Post Marketing Surveillance (XIENCE PRIME SV Japan PMS)CompletedNCT02513719Results posted
• XIENCE PRIME Everolimus Eluting Coronary Stent System (EECSS) China Single-Arm StudyCompletedNCT01894152Results posted
• Remote Device Interrogation In The Emergency DepartmentCompletedNCT01871090Not applicableResults posted
• A Clinical Evaluation of the MINI TREK RX 1.20 mm Coronary Dilatation Catheter in Stenotic LesionsCompletedNCT01186198Results posted
• Retrospective Palivizumab Study in Children With Hemodynamically Significant Congenital Heart DiseaseCompletedNCT01075178Results posted
• Palivizumab for Prevention of Severe Respiratory Syncytial Virus Infection in Russian ChildrenCompletedNCT01006629Phase 2/3Results posted
• Safety and Efficacy Study Comparing ABT-335 Coadministered With Atorvastatin and Ezetimibe to Atorvastatin Coadministered With Ezetimibe in Subjects With Multiple Abnormal Lipid (Fat) Levels in the BloodCompletedNCT00639158Phase 3Results posted
• Evaluate Safety and Efficacy of ABT-335 in Combination With Rosuvastatin Calcium in Subjects With Multiple Abnormal Lipid Levels in the BloodCompletedNCT00300482Phase 3Results posted
• Evaluate Safety and Efficacy of ABT-335 in Combination With Atorvastatin in Subjects With Multiple Abnormal Lipid Levels in the BloodCompletedNCT00300469Phase 3Results posted
• Evaluate Safety and Efficacy of ABT-335 in Combination With Simvastatin in Subjects With Multiple Abnormal Lipid Levels in the BloodCompletedNCT00300456Phase 3Results posted
• Study to Evaluate the Long-Term Safety and Efficacy of ABT-335, in Combination With Three Different Statins in Subjects With Mixed Dyslipidemia.CompletedNCT00300430Phase 3Results posted
• Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE TrialActive, not recruitingNCT03108456Not applicable
• ABSORB Post-Approval Clinical StudyWithdrawnNCT02943616Not applicable
• Remote Interrogation in Rural Emergency DepartmentsWithdrawnNCT02421549Phase 4
• St. Jude Medical Product Longevity and Performance (SCORE) RegistryCompletedNCT01754064
• AnalyST Treadmill StudyCompletedNCT00949000Not applicable
• Angio-Seal Evolution Device RegistryCompletedNCT00817349
• The Ischemia Modified Albumin In Diagnosing Ischemic New EventsTerminatedNCT00355992
• Observational Study of Prosthetic Tissue Aortic and Mitral Heart ValveCompletedNCT00329667Not applicable
• B-Left HF: Biventricular Versus Left Univentricular Pacing With Implantable Cardiac Defibrillator (ICD) Back-Up in Heart Failure PatientsCompletedNCT00187213Not applicable
• Comparative Efficacy Evaluation of Lipids When Treated With Niaspan & Statin or Other Lipid-Modifying Therapies-COMPELLCompletedNCT00079638Phase 4